My first thought is that asking an NHS trust whether they have implemented NICE guidance on a particular topic doesn't tell you very much.
It doesn't tell you *how* they might have implemented it, or that an affirmative answer means total compliance. #ImplementNICEmecfs
There also seem to be assumptions made about what implementation means on both the part of the trusts and @actionforme
Let's take a look at question 1:
Has [NHS trust] implemented NG206?
25 trusts answered "yes", but @actionforme say 25 "services" said they had implemented NG206.
Is that because they reply was received from the ME/CFS service itself, or was the assumption made that the trust had a service if they answered affirmatively?
This concerns me because NG206 makes reference to *all* care that a pwME might receive in an NHS hospital/facility, not just within an ME service.
Therefore implementation of guidance should be across all services provided by the trust.
NG206 has sections on how ppl w/ severe/very severe ME should be cared for in hospital under any/all circumstances; safeguarding of children/vulnerable adults w/ ME; primary care review (care/support plans) etc, which apply to all trusts, whether they have an ME service or not.
Therefore, all trusts should be implementing NG206.
Maybe a better question here would have been:
"Does [NHS trust] have policies/procedures for the care and consideration of pwME (particularly those with severe or very severe ME)? If so, please provide a brief description."
But I guess if 37 trusts really did respond saying that the question was not relevant to them because they didn't have an ME/CFS service, I guess that answers the question of whether they have even read and considered the guidance.
Shockingly poor indeed! @actionforme
@actionforme Q1a asks: If NG206 has not been implemented, what is the timetable and deadline?
That 85 trusts responded to say that the guidance wasn't relevant to them, indicates again that they have not even read it.
@actionforme Q2 asks: How many patients with a diagnosis
of ME/CFS are receiving care from [NHS Trust]?
But does that mean care for anything within the trust? Or just those receiving care as part of the ME service?
It would be interesting to know how many trusts keep a note of an ME/CFS diagnosis for reference outside the ME service itself, so that those pts can receive appropriate care and consideration across the trust.
But again, the nos of NAs says it all. 😣
Q3 is the first question that asks specifically about something that is provided by an ME/CFS service - the care and support plan.
Yet only 1 in 5 pts mentioned in answer to the previous question were accounted for.
Q4 asks: What training has been provided
by [NHS Trust] for healthcare professionals on the
implementation of NG206?
A massive 88% answered that it was not applicable. 😲
This is super concerning, given the earlier point about how pwME are potentially affected by the care they receive across all services in an NHS trust.
I found this question confusing as to what it was asking, as NG206 doesn't specifically make this recommendation.
Is it in reference to the changes in guidance?
afaik it's ultimately up to a service as to how it communicates that sort of information.
There are 1000s of bits of NICE guidance, that change weekly. Keeping track of that across an organisation is not usually done centrally.
However, in this case, it clearly is important that this information is disseminated across the whole trust, and the ME service is probably best placed to do it.
But, again, we shouldn't assume that orgs work in the way we necessarily want or need them to.
Unfortunately.
Yesterday, whilst out while the sun was high, I noticed this phenomenon - of millions of bugs and seeds spiraling round the sun.
I could only see it because the sun was obscured, so I tried to capture it (somewhat unsuccessfully) in this video... instagram.com/p/CswF5-JuTF3/
This photo does a slightly better job, but it's hard to get the focus point right.
As your eyes keep refocusing, it's just bugs all the way up!
I found this article on this phenomenon (ft @j_chapman2), but I'm trying to find a better video of the effect.
But maybe it's just best witnessed IRL.
(with appropriate precautions 😎)
Saw this meme quote (ht @TomKindlon) and it's got me thinking again about how we measure subjective outcomes, particularly wrt how trials and stats work (or don't, in this case).
First of all though - I don't know whether haematologists are any better placed to understand this or not - I can't find the origin of the quote (the earliest I can find is here (tagged as 26 Sept 2016): facebook.com/ADayintheLifeo…) - but the substance is broadly true.
The reason these measures are inappropriate in trials is because everyone's experience of pain (and fatigue) is different.
Yet a trial will seek to average a score across a cohort to produce a group baseline or outcome for comparison.
I've been wondering why, over the past few days, I've been feeling really upset by all the talk about this Panorama ADHD documentary.
Then I realised.
That you have know what's wrong with you to get any help.
But what if you don't. What if life has become impossible, but you have no idea why?
You reach out, and eventually get put on a waiting list for what you hope will be a proper assessment of what might be wrong, and possible help at the end.
You wait 3 and a half years.
Finally, the appointment comes, and to your disappointment, you are not given any kind of assessment, but put on a generic 12-week course of one-size-fits-all talking therapy.
And of course I hadn't realised how far back this goes.
Here is Sir William Allchin's lecture from 1886 (HT @TeunkeA), who reminds us that "functional" was used as the contrast of "organic" in the late 19th century. archive.org/details/b22267…
This is fascinating to me, because I was studying molecular medicine and virology at uni at exactly the time (early 1990s) when certain people were trying to revive the notion of "hysteria", "conversion disorder" and "functional disease", albeit in a new guise
In the 19thC article above, Allchin accepts that the term can be a useful placeholder for diseases for which the cause and pathology are unknown, but you can sense his concern that it is in danger of becoming an entity in its own right.